ARLINGTON, Va., July 5, 2022 /PRNewswire/ — The AES Corporation (NYSE: AES) will host a conference call on Friday, August 5, 2022 at 10:00 a.m. Eastern Time (ET) to review its second quarter 2022 financial results. The call will include prepared remarks and a question and answer session….
Related Posts
Global Cable Blowing Equipment Market (2022 to 2027) – Increasing Penetration of FttH/FttB to Create Opportunities for Cable Blowers
DUBLIN, Oct. 28, 2022 /PRNewswire/ — The “Global Cable Blowing Equipment Market by Power (Hydraulically Powered, Pneumatically Powered, Electric-driven, Drill-driven),…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
Vermilion Energy Corrects Ex-Dividend Date for the Q3 2022 Dividend Payment
CALGARY, AB, Sept. 20, 2022 /PRNewswire/ – Vermilion Energy Inc. (“Vermilion”) (TSX: VET) (NYSE: VET) announces a correction to the…